Thomas Dustin, Anderson David, Hulten Edward, McRae Fiora, Ellis Shane, Malik Jamil A, Villines Todd C, Slim Ahmad M
Cardiology Service, Brooke Army Medical Center, San Antonio, TX, USA.
Cardiology Service, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Vascular. 2015 Jun;23(3):234-9. doi: 10.1177/1708538114546207. Epub 2014 Aug 18.
Abdominal aortic aneurysm (AAA) is common with unacceptably high rates of mortality and morbidity with unknown rates of complications after repair in the Department of Defense (DoD).
All patients treated at a DOD or VA clinic or medical facility with a diagnosis of AAA identified by ICD-9 code search were identified by Patient Administration Systems and Biostatistics Activity (PASBA) using the Standard Inpatient Data Record (SIDR) and Composite Ambulatory Patient Encounter Record (CAPER) from January 2006 till December 2011. The primary outcome was death, myocardial infarction (MI), stroke, and cardiac arrhythmia between subjects who underwent endovascular aortic repair (EVAR) or open aortic repair (OAR).
A total of 8314 patients were screened to identify 632 patients who underwent surgical repair of non-ruptured AAA. EVAR was performed in 497 patients (78.6%) and OAR in 135 patients (21.4%). Mortality at 30 days was less common in EVAR patients (1.6% vs. 6.7%, p = 0.004), but was not sustained (16.9% vs. 17.8%, p = 0.797). Mean survival free from mortality was not different between the two groups (EVAR vs. OAR: 6.14 ± 0.13 years vs. 6.11 ± 0.22 years, p = 0.378). The composite endpoint of MI, stroke, arrhythmia, or death was not different between groups at 30 days (EVAR vs. OAR: 12.9% vs. 14.1%, p = 0.774) or in long-term follow-up population (EVAR vs. OAR: 40.6% vs. 31.9%, p = 0.073) though there was a trend toward higher event rates in the EVAR. The composite endpoint of MI, stroke, and arrhythmia occurred in 198 patients (31%).
EVAR was associated with lower 30-day mortality rates; however, this benefit was not sustained in longer-term follow-up. There is no difference in the rates of stroke, myocardial infarction, or cardiac arrhythmia at 30 days or in long-term follow-up.
腹主动脉瘤(AAA)很常见,其死亡率和发病率高得令人难以接受,在国防部(DoD)修复后的并发症发生率未知。
利用患者管理系统和生物统计学活动(PASBA),通过国际疾病分类第九版(ICD-9)编码搜索,从2006年1月至2011年12月在国防部或退伍军人事务部(VA)诊所或医疗机构接受治疗且诊断为AAA的所有患者均通过标准住院数据记录(SIDR)和综合门诊患者就诊记录(CAPER)进行识别。主要结局是接受血管内主动脉修复(EVAR)或开放性主动脉修复(OAR)的受试者之间的死亡、心肌梗死(MI)、中风和心律失常。
共筛查了8314例患者,以识别632例接受非破裂性AAA手术修复的患者。497例患者(78.6%)接受了EVAR,135例患者(21.4%)接受了OAR。EVAR患者30天死亡率较低(1.6%对6.7%,p = 0.004),但这种情况未持续(16.9%对17.8%,p = 0.797)。两组间无死亡的平均生存期无差异(EVAR对OAR:6.14±0.13年对6.11±0.22年,p = 0.378)。MI、中风、心律失常或死亡的复合终点在30天时两组间无差异(EVAR对OAR:12.9%对14.1%,p = 0.774),在长期随访人群中也无差异(EVAR对OAR:40.6%对31.9%,p = 0.073),尽管EVAR组事件发生率有升高趋势。MI、中风和心律失常的复合终点发生在198例患者(31%)中。
EVAR与较低的30天死亡率相关;然而,这种益处在长期随访中未持续。30天或长期随访时中风、心肌梗死或心律失常的发生率无差异。